H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
21%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Treatment outcome for osteosarcoma in children. The experience of single institution

Stefan Popadiuk, Małgorzata Szumera, Jacek Gołębiewski, Katarzyna Sznurkowska, Maria Korzon

Med Sci Monit 2003; 9(4): 38-40

ID: 428633


Background: Osteosarcoma is the most frequent primary bone malignancy in children. Preoperative and postoperative chemotherapy and radical surgery are used in treatment of osteosarcoma.Material/Methods: In the years 1995 –1999 twenty patients with osteosarcoma were treated. All children were given preoperative chemotherapy, then radical resection of primary tumor and finally postoperative chemotherapy was introduced. Nineteen of twenty patients received two drugs chemotherapy: adriamycin /cisplatin.A median follow-up is 6.2 years.Results: Disease Free Survival (DFS) and Event Free Survival (EFS) for all the group were 0.7 and 0.45, and for non-metastatic patients DFS and EFS were 0.78 and 0.50 respectively. In 55 %of patients limb–sparing surgery was performed, the others under-went amputation. No severe, late toxic effects were observed after the treatment.Conclusions: The results confirmed the efficacy of EOI protocol in pediatric patients with osteosarcoma. A relatively large number of secondary mtetastases after completion of therapy is still unsatisfactory.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree